Carasent ASA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Carasent ASA - overview
Established
1997
Location
Oslo, -, Norway
Primary Industry
Software
About
Based in Oslo, Norway, and founded in 1997, Carasent ASA operates as a software-as-a-service (SaaS) and product-as-a-service (PaaS) company offering e-health solutions for private healthcare providers. In May 2018, Carasent ASA, a portfolio company of Vitruvian Partners, acquired Evimeria EMR AB. The firm, as of May 2024, is trading on the Oslo Stock Exchange under the ticker symbol CARA and ISIN NO0010123060 and is led by its CEO, Daniel Öhman. The company offers a range of mission-critical digital healthcare solutions designed to improve efficiency and quality, streamline workflows, and eliminate inefficiencies in healthcare and occupational health sectors.
Carasent’s key products include Webdoc, a SaaS practice management system for primary and specialist care clinics in Sweden; Metodika, a medical record system for medium to large clinics; Medrave, a business intelligence system for visualizing patient data; HPI, which provides occupational health services; Ad Curis, a platform for rehabilitation and mental health care; and Ad Opus, a system for work integration social enterprises. The firm as of May 2024, serves more than 3,000 providers from small clinics to large hospitals.
Primary Industry
Software
Sub Industries
Medical Software, Application Integration Software, Analytics & Performance Software
Website
www.carasent.com
Verticals
Cloud Computing, Cloud Computing
Total Amount Raised
Subscriber access only
Carasent ASA - timeline of key events
Carasent ASA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.